Wendy Chapman is the Chief Operating Officer and Vice President of Clinical Operations at Viventia Biotechnologies Inc. Ms. Chapman joined Viventia in February of 2006 and is responsible for the planning and direction of all operational policies, initiatives and as well as the attainment of financial and operational goals. Ms. Chapman has more than 20 years of experience in clinical drug development at several pharmaceutical and contract research companies in Canada and the United States. Prior to joining Viventia, Ms. Chapman was the Canadian Business Unit Head for AAI Pharma Inc..
|
